Erratum: Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells (Nature Biotechnology (2011) 29 (1117-1119))

About: This article is published in Nature Biotechnology.The article was published on 2012-01-01 and is currently open access. It has received 6 citations till now. The article focuses on the topics: Epigenome.

Full text

112 volume 30
number 1
JAnuArY 2012 nature biotechnology
Erratum: In defense of life sciences venture investing
Bruce L Booth & Bijan Salehizadeh
Nat. Biotechnol. 29, 579–583 (2011); published online 11 July 2011; corrected after print 11 July 2011
In the version of this article initially published, the x axis in Figure 1 should not have contained the category “Technology.” In addition, on p. 579,
col. 3, paragraph 1, the last sentence should have read “comparative realized performance” instead of “comparative performance.” The errors have
been corrected in the HTML and PDF versions of the article.
Erratum: Donor cell type can influence the epigenome and differentiation
potential of human induced pluripotent stem cells
Kitai Kim, Rui Zhao, Akiko Doi, Kitwa Ng, Juli Unternaehrer, Patrick Cahan, Huo Hongguang, Yuin-Han Loh, Martin J Aryee,
M William Lensch, Hu Li, James J Collins, Andrew P Feinberg & George Q Daley
Nat. Biotechnol. 29, 1117–1119 (2011); published online 27 November 2011; corrected after print 9 January 2012
In the version of this article initially published, the received date was incorrect. The correct received date is 17 February 2011. The error has been
corrected in the HTML and PDF versions of the article.
Erratum: Move over ZFNs
Laura DeFrancesco
Nat. Biotechnol. 29, 681–684 (2011); published online 5 August 2011; corrected after print 9 January 2012
In the version of this article initially published, Figure 1 incorrectly cites Romer et al., Plant Physiol., 2009, as the article that demonstrates “Promoter
customized to bind 3 TAL effectors.” It should have cited Romer et al., Proc. Nat. Acad. Sci. USA (2009). The error has been corrected in the HTML
and PDF versions of the article.
Corrigendum: Biotechs follow big pharma lead back into academia
Jim Kling
Nat. Biotechnol. 29, 555–556 (2011); published online 8 July 2011; corrected after print 9 January 2012
In the version of this article initially published, Gilead Biosciences was incorrectly named. The correct name is Gilead Sciences. The error has been
corrected in the HTML and PDF versions of the article.
Corrigendum: New models emerge for commercializing university assets
Nuala Moran
Nat. Biotechnol. 29, 774–775 (2011); published online 8 September 2011; corrected after print 9 January 2011
In the version of this article initially published, in Box 1, the CEO at VPD is David Collier, not Michael Collier. On p. 775, second column, the
University of Pennsylvania has 400 invention disclosures a year, and not, as stated, Penn State. The error has been corrected in the HTML and
PDF versions of the article.
Corrigendum: Drugmakers use real-world patient data to calibrate product
development
Cormac Sheridan
Nat. Biotechnol. 29, 778–779 (2011); published online 8 September 2011; corrected after print 9 January 2012
In the version of this article initially published, Medco Health Solutions’ location was given as Wilmington, Delaware; it should have been Franklin
Lakes, New Jersey. On p. 779, in the first paragraph, left column, UBC is said to be HealthCore’s parent company. In fact, Wellpoint is HealthCore’s
parent company. The errors have been corrected in the HTML and PDF versions of the article.
errata and corrigenda
npg
© 2012 Nature America, Inc. All rights reserved.